1. Grundmann, H. et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet. Infect. Dis 17, 153–163,
https://doi.org/10.1016/S1473-3099(16)30257-2
(2017).
2. ANTIMICROBIAL RESISTANCE Global Report on Surveillance. (World Health Organization, 2014).
3. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. Report No. WHO/EMP/IAU/2017.12, (World Health Organization, 2017).
4. Rohmer, M., Grosdemange-Billiard, C., Seemann, M. & Tritsch, D. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs. Curr Opin Investig Drugs 5, 154–162 (2004).
5. Gräwert, T., Groll, M., Rohdich, F., Bacher, A. & Eisenreich, W. Biochemistry of the non-mevalonate isoprenoid pathway. Cell Mol Life Sci 68, 3797–3814 (2011).